SCOPUS 정보 검색 플랫폼

Japanese Journal of Clinical Oncology

Volumn 30, Issue 11, 2000, Pages 469-471

On the immunomodulating effects of anti-cancer drugs and their therapeutic exploitation

(1) Mihich, E a

a ROSWELL PARK CANCER INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FLUOROURACIL; INTERLEUKIN 1; MERCAPTOPURINE; METHOTREXATE; MITOMYCIN; NITROSOUREA; PACLITAXEL; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; VINBLASTINE; VINCRISTINE;

ANGIOGENESIS; CANCER; CANCER CHEMOTHERAPY; DOSE RESPONSE; DRUG MECHANISM; DRUG MISUSE; DRUG SCREENING; EDITORIAL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; NONHUMAN; TUMOR IMMUNITY; TUMOR MODEL;

EID: 0034522104 PISSN: 03682811 EISSN: None Source Type: Journal
DOI: 10.1093/jjco/hyd127 Document Type: Editorial

Times cited : (12)

References (18)

1
- 0026444990
- Angiostatic activity of anti-cancer agents in the chick embryo chorioallantoic membrane (CHE-CAM) assay
- In: Steiner R, Langer R, editors; Key Principles - Science - Technology - Medicine. Basle: Birkhauser Verlag
- (1992) Angiogenesis , pp. 449-454
- Steiner, R.¹

2
- 0033643472
- Historical overview of biologic response modifiers
- (2000) Cancer Invest , vol.18 , pp. 456-466
- Mihich, E.¹

3
- 0002303262
- Immunomodulation by anti-cancer drugs
- In: DeVita VT, Hellman S, Rosenburg SA, editors; Philadelphia, PA: JB Lippincott
- (1991) Biologic Therapy of Cancer , pp. 776-786
- Mihich, E.¹ Ehrke, M.J.²

4
- 0001670797
- Immunopharmacology of anti-cancer agents
- In: Hadden JW, Szentivanyi V, editors; New York: Plenum Press
- (1996) Immunopharmacology Reviews , vol.2 , pp. 103-127
- Ehrke, M.J.¹ Mihich, E.²

5
- 0006748956
- Mihich E, Fefer A, editors; Washington, DC: National Cancer Institute
- (1983) Biological Response Modifiers: Subcommittee Report. Monograph No. 63

6
- 84985438206
- Mihich E, editor; New York: Academic Press
- (1967) Immunity, Cancer and Chemotherapy: Basic Relationships on the Cellular Level

7
- 0034032882
- Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer
- (2000) Cancer Res , vol.60 , pp. 1878-1886
- Browder, T.¹ Butterfield, C.E.² Kraling, B.M.³ Shi, B.⁴ Marshall, B.⁵ O'Reilly, M.S.⁶

8
- 0014254064
- Prevention of therapeutically-induced regression of sarcoma 180 by immunologic enhancement
- (1968) Cancer Res , vol.28 , pp. 245-250
- Ferrer, J.F.¹ Mihich, E.²

9
- 0014492975
- Combined effects of chemotherapy and immunity against leukemia L1210 in DBA/2 mice
- (1969) Cancer Res , vol.29 , pp. 848-854
- Mihich, E.¹

10
- 0030806768
- Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production
- (1997) Immunopharmacology , vol.37 , pp. 63-73
- Mullins, D.W.¹ Alleva, D.G.² Burger, C.J.³ Elgert, K.D.⁴

11
- 0001146824
- Doxorubicin (DOX)-induced immunomodulation of murine peritoneal exudate cells (PECs): Effect on cytokine mRNA levels and secreted protein
- (1997) Proc Am Assoc Cancer Res , vol.38 , pp. 119
- Berleth, E.¹ Ujhazy, P.² Henn, A.³ Meer, J.⁴ Dolnick, B.⁵ Ehrke, M.J.⁶

12
- 0027938275
- Doxorubicin induced DNA degradation in murine thymocytes
- (1994) Mol Pharmacol , vol.46 , pp. 901-908
- Zaleskis, G.¹ Berleth, E.² Ehrke, M.J.³ Mihich, E.⁴

13
- 0027892990
- Development of a safe and effective adriamycin plus interleukin 2 therapy against both adriamycin sensitive and resistant lymphomas
- (1993) Oncol Res , vol.5 , pp. 373-381
- Ho, R.L.X.¹ Maccubbin, D.² Zaleskis, G.³ Krawczyk, C.⁴ Wing, K.⁵ Mihich, E.⁶

14
- 0027849596
- Immunological responses critical to the therapeutic effects of adriamycin plus interleukin 2 in C57B1/6 mice bearing syngeneic EL4 lymphomas
- (1993) Oncol Res , vol.5 , pp. 363-372
- Ho, R.L.X.¹ Maccubbin, D.² Ujhazy, P.³ Zaleskis, G.⁴ Eppolito, C.⁵ Mihich, E.⁶

15
- 0029953959
- Demonstration of long-term specific anti-primary EL4 lymphoma immunity in 2-year old cured mice
- (1996) Cancer Immunol Immunother , vol.42 , pp. 221-230
- Ehrke, M.J.¹ Verstovsek, S.² Zaleskis, G.³ Ho, R.L.X.⁴ Ujhazy, P.⁵ Maccubbin, D.⁶

16
- 0021965715
- Augmentation of the cell-mediated cytotoxic response induced in mixed cell culture by adriamycin
- (1985) Jpn J Cancer Res , vol.76 , pp. 414-419
- Arinaga, S.¹ Akiyoshi, T.² Tsuji, H.³

17
- 0022447001
- Augmentation of the generation cell mediated cytotoxicity after a single dose of adriamycin in cancer patients
- (1986) Cancer Res , vol.46 , pp. 4213-4216
- Arinaga, S.¹ Akiyoshi, T.² Tsuji, H.³

18
- 0023747027
- Biological response modifiers in therapeutics: Potential and limitations
- (1988) Cancer Detect Prev , vol.12 , pp. 531-535
- Mihich, E.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.